Chemical Variations on the p53 Reactivation Theme
AbstractAmong the tumor suppressor genes, p53 is one of the most studied. It is widely regarded as the “guardian of the genome”, playing a major role in carcinogenesis. In fact, direct inactivation of the TP53 gene occurs in more than 50% of malignancies, and in tumors that retain wild-type p53 status, its function is usually inactivated by overexpression of negative regulators (e.g., MDM2 and MDMX). Hence, restoring p53 function in cancer cells represents a valuable anticancer approach. In this review, we will present an updated overview of the most relevant small molecules developed to restore p53 function in cancer cells through inhibition of the p53-MDMs interaction, or direct targeting of wild-type p53 or mutated p53. In addition, optimization approaches used for the development of small molecules that have entered clinical trials will be presented. View Full-Text
Share & Cite This Article
Ribeiro, C.J.A.; Rodrigues, C.M.P.; Moreira, R.; Santos, M.M.M. Chemical Variations on the p53 Reactivation Theme. Pharmaceuticals 2016, 9, 25.
Ribeiro CJA, Rodrigues CMP, Moreira R, Santos MMM. Chemical Variations on the p53 Reactivation Theme. Pharmaceuticals. 2016; 9(2):25.Chicago/Turabian Style
Ribeiro, Carlos J.A.; Rodrigues, Cecília M.P.; Moreira, Rui; Santos, Maria M.M. 2016. "Chemical Variations on the p53 Reactivation Theme." Pharmaceuticals 9, no. 2: 25.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.